<?xml version="1.0" encoding="UTF-8"?><akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xmlns:fmx="http://formex.publications.europa.eu/schema/formex-05.21-20110601.xd" xmlns:leos="urn:eu:europa:ec:leos" xmlns:xs="http://www.w3.org/2001/XMLSchema"><bill name=""><meta xmlns:fn="http://www.w3.org/2005/xpath-functions"><identification source="~COM"><FRBRWork><FRBRthis value=""/><FRBRuri value=""/><FRBRdate date="2999-01-01" name=""/><FRBRauthor href=""/><FRBRcountry value=""/></FRBRWork><FRBRExpression><FRBRthis value=""/><FRBRuri value=""/><FRBRdate date="2999-01-01" name=""/><FRBRauthor href=""/><FRBRlanguage language="eng"/></FRBRExpression><FRBRManifestation><FRBRthis value=""/><FRBRuri value=""/><FRBRdate date="2999-01-01" name=""/><FRBRauthor href=""/></FRBRManifestation></identification></meta><preface><longTitle><p><docStage/><docType>COMMISSION IMPLEMENTING REGULATION (EU) 2020/43</docType>of 17 January 2020<docPurpose>amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit</docPurpose></p></longTitle><container name="EEArelevance"><p>(Text with EEA relevance)</p></container></preface><preamble><formula name="actingEntity"><p>THE EUROPEAN COMMISSION,</p></formula><citations><citation><p>Having regard to the Treaty on the Functioning of the European Union,</p></citation><citation><p>Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and the Council<authorialNote placement="bottom" marker="1"><p>OJ L 152, 16.6.2009, p. 11.</p></authorialNote>, and in particular Article 14 in conjunction with Article 17 thereof,</p></citation><citation><p>Having regard to the opinion of the European Medicines Agency formulated on 21 February 2019 by the Committee for Medicinal Products for Veterinary Use,</p></citation></citations><recitals xml:id="recs_d93e76"><intro><p>Whereas:</p></intro><recital xml:id="rec_d93e79"><num>(1)</num><p>Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (&apos;MRL&apos;) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a Regulation.</p></recital><recital xml:id="rec_d93e89"><num>(2)</num><p>Table 1 of the Annex to Commission Regulation (EU) No 37/2010<authorialNote placement="bottom" marker="2"><p>Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).</p></authorialNote> sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.</p></recital><recital xml:id="rec_d93e108"><num>(3)</num><p>The substance ciclesonide is not included in that table.</p></recital><recital xml:id="rec_d93e114"><num>(4)</num><p>An application for the establishment of MRLs for ciclesonide in equidae has been submitted to the European Medicines Agency (&apos;EMA&apos;).</p></recital><recital xml:id="rec_d93e124"><num>(5)</num><p>The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended the establishment of an MRL for ciclesonide in equidae tissues, excluding animals producing milk for human consumption.</p></recital><recital xml:id="rec_d93e130"><num>(6)</num><p>According to Article 5 of Regulation (EC) No 470/2009, the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.</p></recital><recital xml:id="rec_d93e136"><num>(7)</num><p>The EMA has considered that the extrapolation of the MRL for ciclesonide from equidae to other food-producing species is not appropriate at this time due to insufficient data.</p></recital><recital xml:id="rec_d93e142"><num>(8)</num><p>Regulation (EU) No 37/2010 should therefore be amended accordingly.</p></recital><recital xml:id="rec_d93e148"><num>(9)</num><p>The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,</p></recital></recitals><formula name="enactingFormula"><p>HAS ADOPTED THIS REGULATION:</p></formula></preamble><body><article xml:id="art_d93e157"><num>Article 1</num><heading/><paragraph><content><p>The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.</p></content></paragraph></article><article xml:id="art_d93e163"><num>Article 2</num><heading/><paragraph><content><p>This Regulation shall enter into force on the twentieth day following that of its publication in the <i>Official Journal of the European Union</i>.</p></content></paragraph></article><clause><content><p>This Regulation shall be binding in its entirety and directly applicable in all Member States.</p></content></clause></body><conclusions><p>Done at Brussels, 17 January 2020.</p><block name="signatory"><signature><organization refersTo="">For the Commission</organization><role refersTo="">The President</role><person refersTo="">Ursula VON DER LEYEN</person></signature></block></conclusions></bill></akomaNtoso>